Analyst consensus rating

Galectin Therapeutics Analyst Rating: Strong Buy

Direct answer

Galectin Therapeutics's consensus rating is Strong Buy.

1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $11.00.
Forecast evidence checked November 18, 2026.

Get free Galectin Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$2.91
Average price target
$11.00
High price target
$11.00
Low price target
$11.00
Low target gap
+278%
Target upside
+278%
High target gap
+278%
Target range width
0%
Consensus rating
Strong Buy
Analysts
1
Evidence date
November 18, 2026
Valid through
November 25, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Galectin Therapeutics?

Galectin Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $11.00.

How far are Galectin Therapeutics's low and high targets from the recorded price?

The low target implies +278%, while the high target implies +278%.

How many analysts are included in Galectin Therapeutics's consensus?

The verified consensus includes 1 analysts.

How is Galectin Therapeutics's target upside or downside calculated?

The average target of $11.00 is divided by the recorded price of $2.91, then one is subtracted to produce +278%. This does not guarantee a future return.

When was Galectin Therapeutics's analyst forecast verified?

The data was verified on 2026-11-18. The dataset is valid through 2026-11-25.